Frequently asked questions
Sermorelin FAQ: Answers Drawn From the Research Record
Direct answers to the most-asked sermorelin questions, each carried back to the study or the regulatory record behind it.
What is sermorelin?
Sermorelin is a synthetic 29-amino-acid peptide — the amidated GHRH(1-29) fragment — corresponding to the amino-terminal 1-29 residues of the 44-amino-acid hypothalamic hormone GHRH, and the shortest fragment that retains full activity at the GHRH receptor [3]. It was previously FDA-approved as a pediatric growth-hormone-deficiency drug (NDA 020443), withdrawn from the US market in 2008 for commercial reasons [5], and is now prepared by compounding pharmacies.
What does sermorelin do to the body?
Sermorelin binds GHRH receptors on anterior-pituitary somatotrophs and activates the Gs / adenylate cyclase / cAMP / PKA pathway, prompting the pituitary to release the body's own growth hormone in its natural pulsatile pattern; downstream, the liver makes more IGF-1 [3]. Because it acts upstream rather than supplying exogenous growth hormone, somatostatin and IGF-1 negative feedback remain intact [4].
How does sermorelin compare to CJC-1295?
Both are GHRH-class peptides that stimulate the same receptor, but they differ in how long they last. Native GHRH(1-29) has a very short plasma half-life — about 10-12 minutes IV [3]. CJC-1295 uses a Drug-Affinity-Complex (DAC), a maleimide group that binds serum albumin, to greatly extend its duration. The native peptide's brevity is the documented reason longer-acting analogs were developed.
How does sermorelin work to stimulate growth hormone production?
Sermorelin engages the GHRH receptor (a class B G-protein-coupled receptor) on pituitary somatotrophs. Receptor activation raises cAMP via adenylate cyclase and activates protein kinase A, increasing GH gene transcription and triggering pulsatile growth hormone release; it also has a trophic effect on somatotrophs [13]. In healthy men, intravenous GHRH(1-29) elicited growth hormone release at doses as low as 0.25 mcg/kg [3].
Are there other peptides or applications being researched for GHRH analogs?
Yes. A 2025 review surveys GHRH-analog development — both agonists and antagonists — across cancer, regenerative medicine, and metabolic disorders [14], and a 2025 Nature Reviews Endocrinology review synthesizes the broader biology of GHRH and its analogues in health and disease [12]. Stabilized analogs (e.g., tesamorelin; DAC-bearing constructs) are studied alongside native GHRH(1-29).
Does sermorelin need to be refrigerated?
In the research literature, sermorelin acetate is supplied as a lyophilized (freeze-dried) powder because aqueous peptide solutions are prone to degradation. It is reconstituted with a sterile diluent, and once reconstituted it is typically refrigerated [3]. Compounded preparations are made under USP <797> sterile-compounding standards. This describes laboratory and compounding handling, not self-administration guidance.
What route was used to administer sermorelin in studies?
Subcutaneous injection is the primary route in the research literature; intravenous dosing was used in diagnostic and pharmacokinetic studies, and an intranasal route was tested historically but showed only about 3-5% bioavailability [3]. These are descriptions of how studies were conducted, not administration instructions for any individual.
Is sermorelin a steroid?
No. Sermorelin is a 29-amino-acid peptide — the GHRH(1-29) fragment of a hypothalamic hormone — not a steroid. It has no steroid ring structure and does not act on androgen or glucocorticoid receptors. It works by stimulating the pituitary's GHRH receptor to release the body's own growth hormone [3].
Does sermorelin work?
In its historical approved use, once-daily subcutaneous GHRH(1-29) accelerated linear growth in prepubertal GH-deficient children, raising first-year height velocity from about 4.1 to roughly 7-8 cm/year [1]. In healthy older men, 14 days of subcutaneous GHRH(1-29) produced dose-related rises in 24-hour growth hormone and IGF-1 [2]. Rigorous long-term adult anti-aging efficacy data, however, remain limited.
How long does it take for sermorelin to work?
Acutely, a single intravenous dose elevates serum growth hormone for roughly 3 hours despite the peptide's rapid clearance [3]. Sustained GH/IGF-1 changes were measured over 14 days in older men [2] and over months in pediatric growth studies [1]. One pediatric continuous-infusion study saw an early growth hormone rise decline by 3-6 months [9]. These are study time-courses, not a personal results timeline.
Sermorelin vs ipamorelin: what is the difference?
They act on different receptors. Sermorelin is a GHRH analog that stimulates the GHRH receptor on somatotrophs. Ipamorelin belongs to the GHRP class, which acts on the ghrelin / GHS receptor — a distinct pathway. Both ultimately prompt growth hormone release, but through separate mechanisms; the two inputs are additive rather than identical [10].
What is sermorelin used for?
Its only historical FDA-approved indication was evaluation and treatment of growth-hormone deficiency / short stature in children (brand withdrawn in 2008 for commercial reasons) [5]. Beyond that, GHRH(1-29) and its stabilized analogs have been studied in adult GH-axis aging research, cognition, sleep, and body composition. This site presents that literature; it does not present sermorelin as a medicine to self-administer.
Does sermorelin actually help with sleep, or is it waking me up instead?
The largest natural growth hormone pulse occurs during slow-wave sleep, which is why GH-axis research interest centers on nighttime physiology — growth hormone is secreted in pulses, especially during slow-wave sleep. Direct controlled sleep-outcome trials for sermorelin specifically are limited in the audited literature, so individual sleep experiences cannot be predicted from the studies summarized here.
Why was sermorelin studied with bedtime dosing?
The pediatric efficacy study administered GHRH(1-29) subcutaneously at bedtime (30 mcg/kg/day) [1], and the GHRH-analog cognition trial dosed before bedtime [6] — timing that aligns with the body's largest natural growth hormone pulse during slow-wave sleep. This reflects how trials were designed; it is not a dosing recommendation for any individual.
Does sermorelin burn fat?
The strongest body-composition signal in the audited literature comes from a GHRH analog (tesamorelin) cognition trial in older adults: 20 weeks of daily subcutaneous dosing reduced percent body fat by 7.4% [6]. That is a stabilized-analog result, presented factually — it does not establish a proven fat-loss benefit for native sermorelin, and anti-aging / body-composition marketing for sermorelin outpaces the evidence.
Is sermorelin effective for weight loss?
Sermorelin is not a weight-loss drug and has no such approved indication. The closest audited evidence is a 7.4% reduction in percent body fat with a GHRH analog over 20 weeks [6] — a body-composition change in a research setting, not validated weight-loss efficacy for sermorelin. The body-composition marketing outpaces the underlying data.
Does sermorelin affect testosterone?
Sermorelin acts on the growth-hormone axis (GHRH receptor → pituitary growth hormone → IGF-1), not the reproductive axis, and the audited literature does not report it as a testosterone secretagogue. No finding in this site's sources establishes a direct testosterone effect, so any such claim sits outside the evidence summarized here.
Will sermorelin raise my IGF-1 levels?
In research, raising pulsatile growth hormone leads the liver to produce more IGF-1. In healthy older men, 14 days of subcutaneous GHRH(1-29) increased 24-hour IGF-1, and at the high dose GH/IGF-1 parameters no longer differed from young men [2]. A GHRH analog raised IGF-1 by 117%, kept within the physiologic range, over 20 weeks [6]. These describe study cohorts, not an individual prediction.
Does sermorelin build muscle?
The audited literature does not include a controlled muscle-hypertrophy endpoint for sermorelin. Its mechanism raises growth hormone and IGF-1, and body-composition research with a GHRH analog showed reduced body fat [6], but no audited study demonstrates muscle-building per se. Claims of muscle gain go beyond the evidence summarized here.
How does sermorelin differ from direct HGH injections?
Sermorelin acts upstream: it prompts the pituitary to release the body's own growth hormone in pulses, so somatostatin and IGF-1 feedback remain operative. Direct growth hormone supplies the hormone exogenously, bypassing pituitary regulation. A 2006 editorial argued that, as a physiologic secretagogue preserving pulsatile release and feedback, sermorelin may be a more physiologic approach to adult-onset growth hormone insufficiency than recombinant growth hormone [4].
Does sermorelin affect the brain?
In a randomized, double-blind, placebo-controlled trial of 152 older adults (66 with mild cognitive impairment), 20 weeks of a daily subcutaneous GHRH analog had a favorable effect on cognition (P=0.03; executive function P=0.005) [6]. A separate review frames IGF-1 as a neurotrophic factor and the GH/IGF-1 axis as a candidate target in Alzheimer's, with mixed evidence on GHRH-stimulated growth hormone responses [11].
Can sermorelin or GHRH improve cognition in older adults?
The key audited evidence is the SMART trial (NCT00257712): in 152 older adults, 20 weeks of a daily subcutaneous GHRH analog (tesamorelin, 1 mg/day before bedtime) had a favorable cognition effect (P=0.03), raised IGF-1 by 117% within the physiologic range, and reduced body fat by 7.4%, with mild adverse events [6]. That is a stabilized-GHRH-analog result — suggestive rather than a proven sermorelin benefit.